BR112016005601B1 - composto, composição farmacêutica, e usos de um composto - Google Patents

composto, composição farmacêutica, e usos de um composto Download PDF

Info

Publication number
BR112016005601B1
BR112016005601B1 BR112016005601-9A BR112016005601A BR112016005601B1 BR 112016005601 B1 BR112016005601 B1 BR 112016005601B1 BR 112016005601 A BR112016005601 A BR 112016005601A BR 112016005601 B1 BR112016005601 B1 BR 112016005601B1
Authority
BR
Brazil
Prior art keywords
fibrosis
compound
present
pharmaceutically acceptable
weeks
Prior art date
Application number
BR112016005601-9A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112016005601A8 (pt
Inventor
Karen Annette Duggan
Original Assignee
Vectus Biosystems Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903573A external-priority patent/AU2013903573A0/en
Application filed by Vectus Biosystems Limited filed Critical Vectus Biosystems Limited
Publication of BR112016005601A8 publication Critical patent/BR112016005601A8/pt
Publication of BR112016005601B1 publication Critical patent/BR112016005601B1/pt

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR112016005601-9A 2013-09-17 2014-09-17 composto, composição farmacêutica, e usos de um composto BR112016005601B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013903573A AU2013903573A0 (en) 2013-09-17 Compositions for the treatment of hypertension and/or fibrosis
AU2013903573 2013-09-17
PCT/AU2014/000923 WO2015039173A1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis

Publications (2)

Publication Number Publication Date
BR112016005601A8 BR112016005601A8 (pt) 2020-02-18
BR112016005601B1 true BR112016005601B1 (pt) 2021-02-02

Family

ID=52687998

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016005601-9A BR112016005601B1 (pt) 2013-09-17 2014-09-17 composto, composição farmacêutica, e usos de um composto

Country Status (22)

Country Link
US (1) US9458093B2 (cg-RX-API-DMAC10.html)
EP (1) EP3046901B1 (cg-RX-API-DMAC10.html)
JP (1) JP6122548B2 (cg-RX-API-DMAC10.html)
KR (1) KR101736416B1 (cg-RX-API-DMAC10.html)
CN (1) CN105683152B (cg-RX-API-DMAC10.html)
AP (1) AP2016009079A0 (cg-RX-API-DMAC10.html)
AU (1) AU2014324078B2 (cg-RX-API-DMAC10.html)
BR (1) BR112016005601B1 (cg-RX-API-DMAC10.html)
CA (1) CA2924356C (cg-RX-API-DMAC10.html)
DK (1) DK3046901T3 (cg-RX-API-DMAC10.html)
ES (1) ES2655455T3 (cg-RX-API-DMAC10.html)
IL (1) IL244621A (cg-RX-API-DMAC10.html)
MX (1) MX368865B (cg-RX-API-DMAC10.html)
MY (1) MY172557A (cg-RX-API-DMAC10.html)
NO (1) NO3046901T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ717927A (cg-RX-API-DMAC10.html)
PH (1) PH12016500497B1 (cg-RX-API-DMAC10.html)
PL (1) PL3046901T3 (cg-RX-API-DMAC10.html)
RU (1) RU2635564C2 (cg-RX-API-DMAC10.html)
SG (1) SG11201601642WA (cg-RX-API-DMAC10.html)
UA (1) UA118111C2 (cg-RX-API-DMAC10.html)
WO (1) WO2015039173A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3284981B2 (ja) 1998-11-02 2002-05-27 株式会社デンソー 車両用交流発電機およびそのステータの製造方法
US9956166B2 (en) 2013-09-18 2018-05-01 Sorrento Therapeutics, Inc. Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
SG11201707561RA (en) * 2015-03-18 2017-10-30 Vectus Biosystems Ltd Compositions for the treatment of fibrosis and fibrosis-related conditions
NZ736165A (en) * 2015-03-18 2022-07-01 Vectus Biosystems Ltd Compositions for the treatment of kidney and/or liver disease
EP3353147B1 (en) * 2015-09-22 2021-01-13 Vectus Biosystems Limited Synthesis of terphenyl compounds
CN120114438A (zh) * 2016-04-13 2025-06-10 内布拉斯加大学董事会 施用树脂毒素的方法和用树脂毒素治疗心血管疾病的方法
BR112019001510B1 (pt) 2016-07-28 2022-11-08 Vectus Biosystems Limited Composto, e, uso de um composto para manufatura de um medicamento para tratar profilática ou terapeuticamente fibrose pulmonar, ou uma enfermidade relacionada em um indivíduo com fibrose pulmonar ou em risco de desenvolver fibrose pulmonar

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694288B1 (fr) * 1992-06-30 1994-09-09 Rhone Poulenc Agrochimie Phenylbenzamides fongicides et procédés pour les préparer.
EP1768689B1 (en) * 2004-06-11 2014-08-20 Vectus Biosystems Limited Compositions and methods for treatment of cardiovascular disease
AU2006322656B2 (en) * 2005-12-09 2012-03-08 Vectus Biosystems Limited VIP fragments and methods of use
US20120088737A2 (en) * 2009-10-02 2012-04-12 Ajinomoto Co., Inc Novel acyl guanidine derivatives
US9630935B2 (en) * 2013-09-17 2017-04-25 Vectus Biosystems Limited Compositions for the treatment of hypertension and/or fibrosis

Also Published As

Publication number Publication date
PL3046901T3 (pl) 2018-03-30
RU2016112257A (ru) 2017-10-20
PH12016500497B1 (en) 2017-12-13
MX2016003371A (es) 2016-10-21
MY172557A (en) 2019-12-02
CA2924356C (en) 2018-04-03
UA118111C2 (uk) 2018-11-26
IL244621A0 (en) 2016-04-21
MX368865B (es) 2019-08-02
KR20160074471A (ko) 2016-06-28
KR101736416B1 (ko) 2017-05-16
SG11201601642WA (en) 2016-04-28
JP2016532632A (ja) 2016-10-20
AP2016009079A0 (en) 2016-03-31
ES2655455T3 (es) 2018-02-20
NZ717927A (en) 2018-12-21
BR112016005601A8 (pt) 2020-02-18
NO3046901T3 (cg-RX-API-DMAC10.html) 2018-03-17
DK3046901T3 (en) 2018-01-02
IL244621A (en) 2017-04-30
PH12016500497A1 (en) 2016-06-13
RU2635564C2 (ru) 2017-11-14
JP6122548B2 (ja) 2017-04-26
WO2015039173A1 (en) 2015-03-26
CN105683152B (zh) 2017-03-22
CN105683152A (zh) 2016-06-15
AU2014324078B2 (en) 2016-12-15
EP3046901A1 (en) 2016-07-27
CA2924356A1 (en) 2015-03-26
US20160221933A1 (en) 2016-08-04
EP3046901B1 (en) 2017-10-18
US9458093B2 (en) 2016-10-04
AU2014324078A1 (en) 2016-04-07
EP3046901A4 (en) 2017-04-12

Similar Documents

Publication Publication Date Title
ES2655455T3 (es) Composiciones para el tratamiento de hipertensión y/o fibrosis
ES2791539T3 (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresión de DUX4
KR20240021884A (ko) 암을 치료하기 위한 parp 억제제와 조합된 atr 억제제의 용도
JP2004525179A (ja) ジペプチジルペプチダーゼiv阻害剤でのii型糖尿病の処置
JPH11502199A (ja) 大腸ガンの治療のための防護組成物中のr−nsaidの使用
JPH10236978A (ja) 中枢カンナビノイドレセプターcb1の既知の作用薬の利用
BR112015022008A2 (pt) compostos aromáticos substituídos e métodos relacionados para o tratamento da fibrose
WO2014190015A1 (en) Cryopyrin inhibitors for preventing and treating inflammation
ES2253810T3 (es) Uso de r-aines para la prevencion de la enfermedad de alzheimer.
WO2015176539A1 (zh) 异喹啉生物碱衍生物用于制备促进ampk活性的药物的用途
BR112016005606B1 (pt) Composto, composição farmacêutica, e usos de um composto
TW201544108A (zh) 異喹啉生物鹼衍生物用於製備促進ampk活性的藥物之用途
TWI472519B (zh) 含正-亞丁基苯酞之醫藥組成物用於治療肝損傷及改善肝功能
HUT63843A (en) Process for producing new kumarin derivatives and their analogs inhibiting mammal cell proliferation and tumour growth, as well as pharmaceutical comkpositions comprising such compounds
CN106866652A (zh) 具有胰岛素增敏活性的小檗碱12‑位衍生物及其制备方法
BR112020009596A2 (pt) combinações de moduladores duplos de irs/stat3 e anticorpos anti pd-1/pd-l1 para tratar câncer
EP4284352A1 (en) Enhanced anti-proliferative and antitumor immune effects of mitochondria-targeted hydroxyurea
HK1226324A1 (en) Compositions for the treatment of hypertension and/or fibrosis
HK1226324B (en) Compositions for the treatment of hypertension and/or fibrosis
WO2012000306A1 (zh) 含二苯乙烯片段的苯基硝酮类化合物及其用途
EP3753559A1 (en) Colitis improving agent
CN104288145B (zh) 斯诺普利在制备预防肿瘤转移或肿瘤治疗药物中的应用
BR112017019816B1 (pt) Composto, composição farmacêutica, e seus usos
JP2025079327A (ja) Smad非依存的TGF-βシグナル伝達経路阻害剤、及びそれを含むがん浸潤及び/又は転移抑制組成物
JP2019182845A (ja) キヌレニンアミノトランスフェラーゼ2(kat2)阻害剤

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/09/2014, OBSERVADAS AS CONDICOES LEGAIS.